Current research on chronic active Epstein-Barr virus infection in Japan

Plasma Viral MicroRNA Profiles Reveal Potential Biomarkers for Chronic Active Epstein–Barr Virus Infection

(2013) Yoshihiko Kawano et al.   JOURNAL OF INFECTIOUS DISEASES

Application of flow cytometricin situhybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases

(2012) Shinji Kawabe et al.   CANCER SCIENCE

Recurrence of Chronic Active Epstein-Barr Virus Infection from Donor Cells after Achieving Complete Response Through Allogeneic Bone Marrow Transplantation

(2012) Ayako Arai et al.   INTERNAL MEDICINE

T/NK cell type chronic active Epstein–Barr virus disease in adults: an underlying condition for Epstein–Barr virus-associated T/NK-cell lymphoma

(2012) Yasushi Isobe et al.   JOURNAL OF CLINICAL PATHOLOGY

Hydroa Vacciniforme Is Associated with Increased Numbers of Epstein–Barr Virus–Infected γδT Cells

(2012) Yoji Hirai et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

SAP and XIAP deficiency in hemophagocytic lymphohistiocytosis

(2012) Xi Yang et al.   PEDIATRICS INTERNATIONAL

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases

(2011) H. Kimura et al.   BLOOD

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

(2011) J. I. Cohen et al.   BLOOD

Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells

(2011) Seiko Iwata et al.   CANCER SCIENCE

Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV inf

(2011) Emiko Takahashi et al.   HISTOPATHOLOGY

Clinical features of adult-onset chronic active Epstein–Barr virus infection: a retrospective analysis

(2011) Ayako Arai et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Novel Mouse Xenograft Models Reveal a Critical Role of CD4+ T Cells in the Proliferation of EBV-Infected T and NK Cells

(2011) Ken-Ichi Imadome et al.   PLoS Pathogens

Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection

(2010) K Kawa et al.   BONE MARROW TRANSPLANTATION

Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection

(2010) Seiko Iwata et al.   INTERNATIONAL JOURNAL OF CANCER

Multicenter evaluation of prototype real-time PCR assays for Epstein-Barr virus and cytomegalovirus DNA in whole blood samples from transplant recipients

(2010) Yoshinori Ito et al.   MICROBIOLOGY AND IMMUNOLOGY

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Identification of Epstein‐Barr Virus (EBV)–Infected Lymphocyte Subtypes by Flow Cytometric In Situ Hybridization in EBV‐Associated Lymphoproliferative Diseases

(2009) Hiroshi Kimura et al.   JOURNAL OF INFECTIOUS DISEASES

The 2008 WHO classification of lymphomas: implications for clinical practice and translational research

(2009) E. S. Jaffe   Hematology-American Society of Hematology Education Program

Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan

(2008) Emiko Sato et al.   AMERICAN JOURNAL OF HEMATOLOGY

Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T-LPD

(2008) Koichi Ohshima et al.   PATHOLOGY INTERNATIONAL